Abstract: The present invention provides an assay for determining the biochemical fitness of a biochemical species in a mutant replicating biological entity relative to its predecessor. The present invention further provides a continuous fluorogenic assay for measuring the anti-HIV protease activity of protease inhibitor. The present invention also provides a method of administering a therapeutic compound that reduces the chances of the emergence of drug resistance in therapy.
Type:
Application
Filed:
October 11, 2007
Publication date:
April 10, 2008
Applicants:
Government of the United States of America, represented by Secretary, Departmemt of Health and, Board of Trustees of the University of Illinois
Inventors:
John ERICKSON, Sergei GULNIK, Hiroaki MITSUYA, Arun GHOSH